Slocum, Gordon & Co’s Amgen AMGN Stock Holding History

Slocum, Gordon & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+562	New	+$192K	0.14%	68
2025 Q3	–	Sell	-562	Closed	-$157K	–	58
2025 Q2	$157K	Hold	562	–	–	0.13%	63
2025 Q1	$175K	Sell	562 -563	-50%	-$166K	0.13%	57
2024 Q4	$293K	Hold	1,125	–	–	0.24%	45
2024 Q3	$362K	Hold	1,125	–	–	0.15%	46
2024 Q2	$352K	Hold	1,125	–	–	0.26%	41
2024 Q1	$320K	Hold	1,125	–	–	0.24%	43
2023 Q4	$324K	Hold	1,125	–	–	0.28%	40
2023 Q3	$302K	Hold	1,125	–	–	0.26%	43
2023 Q2	$250K	Buy	1,125 +63	+6%	+$14.6K	0.18%	44
2023 Q1	$257K	Hold	1,062	–	–	0.21%	43
2022 Q4	$279K	Buy	+1,062	New	+$285K	0.18%	44

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Slocum, Gordon & Co's AMGN Position: Q2 2026 in Review

Slocum, Gordon & Co opened a new position in Amgen (AMGN) in Q2 2026: 562 shares worth $204K. The stake represents 0.14% of the portfolio and ranks #68 among its holdings. This is a return to the name: Slocum, Gordon & Co previously reported a position in AMGN as recently as Q2 2025.

Slocum, Gordon & Co first reported a position in AMGN in Q4 2022 and has held it in 12 quarters since. The position peaked at $362K in Q3 2024. 937 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Slocum, Gordon & Co held 562 shares of Amgen worth $204K as of Q2 2026.
Amgen was a new Slocum, Gordon & Co position in Q2 2026.
Amgen made up 0.14% of Slocum, Gordon & Co's portfolio in Q2 2026, its #68 holding.
Slocum, Gordon & Co first reported a position in Amgen in Q4 2022 and has held it in 12 quarters since.
Slocum, Gordon & Co's Amgen position peaked at $362K in Q3 2024.
937 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Slocum, Gordon & Co's 13F filing for Q2 2026, filed 23 Jul 2026.